U. Coskun Et Al. , "Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?," NEOPLASMA , vol.54, no.4, pp.348-352, 2007
Coskun, U. Et Al. 2007. Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?. NEOPLASMA , vol.54, no.4 , 348-352.
Coskun, U., Yamac, D., Gulbahar, Ö., Sancak, B., Karaman, N., & Ozkan, S., (2007). Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?. NEOPLASMA , vol.54, no.4, 348-352.
Coskun, UĞUR Et Al. "Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?," NEOPLASMA , vol.54, no.4, 348-352, 2007
Coskun, UĞUR Et Al. "Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?." NEOPLASMA , vol.54, no.4, pp.348-352, 2007
Coskun, U. Et Al. (2007) . "Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?." NEOPLASMA , vol.54, no.4, pp.348-352.
@article{article, author={UĞUR COŞKUN Et Al. }, title={Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?}, journal={NEOPLASMA}, year=2007, pages={348-352} }